HCA Healthcare (NYSE:HCA) Stock: Insider Michael Schlosser Sells 1,200 Shares

HCA Healthcare, Inc. (NYSE:HCA) EVP Michael Schlosser sold 1,200 shares of the company’s stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $494.65, for a total value of $593,580.00. Following the completion of the transaction, the executive vice president owned 1,443 shares of the company’s stock, valued at $713,779.95. The trade was a 45.40% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

HCA Healthcare Price Performance

NYSE:HCA traded down $13.04 during mid-day trading on Friday, reaching $494.44. The company’s stock had a trading volume of 1,462,203 shares, compared to its average volume of 1,355,955. The stock has a market cap of $103.28 billion, a P/E ratio of 16.38, a P/E/G ratio of 1.71 and a beta of 1.11. The company’s fifty day simple moving average is $442.16 and its two-hundred day simple moving average is $445.10. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, October 27th. The company reported $7.22 EPS for the quarter, beating analysts’ consensus estimates of $6.65 by $0.57. The company had revenue of $19.85 billion during the quarter, compared to the consensus estimate of $19.33 billion. HCA Healthcare had a net margin of 8.61% and a negative return on equity of 198.52%. The company’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same quarter in the prior year, the company posted $6.96 EPS. Sell-side analysts expect that HCA Healthcare, Inc. will post 30.15 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 29th. Shareholders of record on Tuesday, December 15th will be paid a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, December 15th. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.34%.

Hedge Funds Weigh In On HCA Healthcare

A number of hedge funds have recently bought and sold shares of HCA. Sunbelt Securities Inc. raised its position in shares of HCA Healthcare by 171.7% during the 1st quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock worth $2,954,000 after buying an additional 3,945 shares in the last quarter. Sei Investments Co. grew its holdings in HCA Healthcare by 27.5% during the first quarter. Sei Investments Co. now owns 467,796 shares of the company’s stock worth $221,380,000 after acquiring an additional 100,764 shares during the period. SEB Asset Management AB bought a new stake in HCA Healthcare in the first quarter worth about $75,534,000. Darsana Capital Partners LP lifted its holdings in HCA Healthcare by 46.7% in the 2nd quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company’s stock valued at $428,879,000 after acquiring an additional 350,000 shares during the last quarter. Finally, Fund 1 Investments LLC bought a new position in shares of HCA Healthcare during the 2nd quarter valued at about $975,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Investors have welcomed expectations that a Democratic-controlled Congress could provide a policy tailwind for hospitals. However, the anticipated relief is not yet enacted and still depends on legislative and funding steps. HCA Healthcare Gains Policy Tailwind
• Positive Sentiment: HCA is expanding AI tools, with its nurse handoff technology heading to 100 hospitals and ambient AI expected to reach 10,000 physicians by year-end. These deployments could support workflow efficiency. AI nurse handoff tool
• Positive Sentiment: Analyst and technical coverage is supportive: Truist reaffirmed its Buy rating, while Zacks highlighted earnings growth, price strength and a bullish moving-average signal. Truist reaffirms Buy rating Zacks stock outlook
• Neutral Sentiment: HCA completed a $6.5 billion senior notes offering. The report confirms the financing but gives limited detail on its use or effect on borrowing costs. Senior notes offering
• Neutral Sentiment: HCA’s AI chief emphasized that delaying a rollout can be appropriate, suggesting a measured approach that may limit near-term adoption while managing implementation risks. HCA AI rollout strategy
• Negative Sentiment: One report flagged potential payer pressure in HCA’s 2027 outlook, a concern for future hospital reimbursement and margins. Payer pressure outlook
• Negative Sentiment: Pomerantz LLP said it is investigating investor claims involving HCA. The announcement provides no findings, but the inquiry may create a legal overhang. Investor investigation announcement

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on HCA shares. Mizuho set a $495.00 price objective on shares of HCA Healthcare in a research report on Wednesday, October 28th. JPMorgan Chase & Co. decreased their price target on HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating for the company in a report on Thursday, August 20th. Morgan Stanley dropped their price objective on shares of HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating on the stock in a research note on Monday, July 27th. Jefferies Financial Group set a $450.00 target price on shares of HCA Healthcare in a research report on Tuesday, July 14th. Finally, Wells Fargo & Company lifted their target price on HCA Healthcare from $381.00 to $468.00 and gave the stock an “equal weight” rating in a research report on Monday. Sixteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $480.13.

About HCA Healthcare

HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine.

The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices.

Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.